Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN954443 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Recombination Activating Gene 2 (RAG2) (C-Term), (AA 348-377) antibody
- Antibody type
- Polyclonal
- Antigen
- KLH conjugated synthetic peptide between 348-377 amino acids from the C-terminal region of Human RAG2. Genename: RAG2
- Description
- Affinity Chromatography on Protein A
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- C-Term,AA 348-377
- Vial size
- 0.4 mL
- Concentration
- 0.25 mg/mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Analysis of mutations from SCID and Omenn syndrome patients reveals the central role of the Rag2 PHD domain in regulating V(D)J recombination.
New genetic associations detected in a host response study to hepatitis B vaccine.
Customised molecular diagnosis of primary immune deficiency disorders in New Zealand: an efficient strategy for a small developed country.
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.
Common genetic variants in candidate genes and risk of familial lymphoid malignancies.
Couëdel C, Roman C, Jones A, Vezzoni P, Villa A, Cortes P
The Journal of clinical investigation 2010 Apr;120(4):1337-44
The Journal of clinical investigation 2010 Apr;120(4):1337-44
New genetic associations detected in a host response study to hepatitis B vaccine.
Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, Hibberd ML, Seielstad M
Genes and immunity 2010 Apr;11(3):232-8
Genes and immunity 2010 Apr;11(3):232-8
Customised molecular diagnosis of primary immune deficiency disorders in New Zealand: an efficient strategy for a small developed country.
Ameratunga R, Woon ST
The New Zealand medical journal 2009 Oct 9;122(1304):46-53
The New Zealand medical journal 2009 Oct 9;122(1304):46-53
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.
Hosgood HD 3rd, Zhang L, Shen M, Berndt SI, Vermeulen R, Li G, Yin S, Yeager M, Yuenger J, Rothman N, Chanock S, Smith M, Lan Q
Occupational and environmental medicine 2009 Dec;66(12):848-53
Occupational and environmental medicine 2009 Dec;66(12):848-53
Common genetic variants in candidate genes and risk of familial lymphoid malignancies.
Liang XS, Caporaso N, McMaster ML, Ng D, Landgren O, Yeager M, Chanock S, Goldin LR
British journal of haematology 2009 Aug;146(4):418-23
British journal of haematology 2009 Aug;146(4):418-23
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of RAG2 Antibody (C-term) Cat.-No AP53570PU-N in K562 cell line lysates (35ug/lane). This demonstrates the RAG2 antibody detected the RAG2 protein (arrow).
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of RAG2 Antibody (C-term) Cat.-No AP53570PU-N in Mouse heart tissue lysates (35ug/lane). This demonstrates the RAG2 antibody detected the RAG2 protein (arrow).
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Formalin fixed and paraffin embedded human tonsil tissue stained with RAG2 Antibody (C-term) Cat.-No AP53570PU-N followed by peroxidase conjugation of the secondary antibody and DAB staining.